Evidence map›Paper›PMID 36992954›Full record

ArticleMalaysian family physician : the official journal of the Academy of Family Physicians of Malaysia2023

Delayed hypersensitivity reaction to allopurinol: A case report.

Che Man Mohammad, Che Alhadi Shahidah, Suriyani Wan Mahmud Wan Fatimah, Amiruddin Salman, Mohd Razib Mohd Zhafri, Ismail Rasimah

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Looking back at 2025: Strengthening primary care evidence for Malaysia, regional partners, and the global health community.Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Che Man MohammadMD (UKM), MMED (USM), Department of Family Medicine, Kulliyyah of Medicine, International Islamic University Malaysia, Indera Mahkota Campus, Kuantan,Pahang, Malaysia.
Che Alhadi ShahidahMBBS (IIUM), MMED (Surgery) (USM), Department of Surgery, Kulliyyah of Medicine, International Islamic University Malaysia, Indera Mahkota Campus, Kuantan, Pahang, Malaysia.
Suriyani Wan Mahmud Wan FatimahMD (UKM), Department of Family Medicine, Kulliyyah of Medicine, International Islamic University Malaysia, Indera Mahkota Campus, Kuantan, Pahang, Malaysia. Email: wsuriyanie@gmail.com.
Amiruddin SalmanMBBCh (University of Cairo), MS (ORL-HNS) (UKM), Fakulti Perubatan, Universiti Sultan Zainal Abidin (UniSZA), Kuala Terengganu, Terengganu, Malaysia.
Mohd Razib Mohd ZhafriMBBS (IIUM), Master of Family Medicine (IIUM), Department of Family Medicine, Kulliyyah of Medicine, International Islamic University Malaysia, Indera Mahkota Campus, Kuantan, Pahang, Malaysia.
Ismail RasimahMBBS (University of Wales College of Medicine), Doctor of Internal Medicine (UKM), AdvMDerm (UKM) Department of Internal Medicine, (Dermatology), Kulliyyah of Medicine, International Islamic University, Malaysia, Indera Mahkota Campus, Kuantan, Pahang, Malaysia.
International Islamic University Malaysia · MYSultan Zainal Abidin University · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allopurinol is the well-known first-line treatment option for symptomatic hyperuricaemia and gout. It is cost-effective particularly for the management of chronic gout. The common early side effects of allopurinol are skin rashes, diarrhoea and nausea. Meanwhile, a dangerous concerning complication is Stevens-Johnson syndrome, which can cause severe morbidity and mortality. Delayed hypersensitivity to allopurinol is rare but should be one of the differential diagnoses if a patient with underlying gout on chronic allopurinol treatment presents with skin rashes. The present case highlights the importance of a high index of suspicion in at-risk patients with underlying gout along with skin rashes on long-term allopurinol treatment to avoid unnecessary patient management.

Indexed as

AllopurinolDelayed hypersensitivityRashesXanthine oxidase inhibitor

Identifiers

PMID36992954
PMCPMC10042238
OpenAlexW4324103084

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.